A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
This pilot study will investigate the safety and effect of etanercept in HIV infection by
studying HIV replication and immune function (as measured by CD4 counts) in individuals with
HIV infection.